Founded in 2021 by Loris Lanzellotti and Alberto Emprin, Excellis is a Turin-based private holding company that invests in deep tech startups founded or co-founded by Italian researchers working at leading European and American universities. The firm co-invests alongside established international venture capital funds at the pre-seed, seed, and Series A stages. Its focus spans embedded technologies, robotics and automation, cleantech, and medtech, with portfolio companies including Annaida Technologies, Mintneuro, Fluorok, and Nagi Bioscience.